Sulfur hexafluoride Disease Interactions
There is 1 disease interaction with sulfur hexafluoride.
Contrast agents (applies to sulfur hexafluoride) cardiopulmonary reactions
Major Potential Hazard, High plausibility. Applicable conditions: Heart Disease
Serious, potentially fatal cardiopulmonary reactions have infrequently occurred during or following the injection of ultrasound contrast agents including sulfur hexafluoride and perfluten. Most serious reactions have been observed within 30 minutes of administration. Patients with unstable cardiopulmonary conditions such as acute myocardial infarction, acute coronary artery syndromes, worsening or unstable congestive heart failure, or serious ventricular arrhythmias may be at increased risk for developing these reactions. Patients receiving these agents should be monitored for acute reactions including cardiac or respiratory arrest, shock, syncope, symptomatic arrhythmias (e.g., atrial fibrillation, tachycardia, bradycardia, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia), hypertension, hypotension, dyspnea, hypoxia, chest pain, respiratory distress, stridor, wheezing, loss of consciousness, and convulsions. Cardiopulmonary resuscitation personnel and equipment should be readily available at all times.
These agents should be used with caution in patients with known or suspected right-to-left, bidirectional, or transient right-to-left cardiac shunts. In such patients, concerns exist that some of the intravenously injected lipid- containing microspheres may bypass filtering by the lung and directly enter the arterial circulation. Occlusion of the microcirculation by these microspheres may result in tissue ischemia. Patients should be closely monitored after administration and assessed for any embolism phenomena.
Switch to professional interaction data
Sulfur hexafluoride drug interactions
There is 1 drug interaction with sulfur hexafluoride.
More about sulfur hexafluoride
- sulfur hexafluoride consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: diagnostic radiopharmaceuticals
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Lexiscan
Lexiscan is used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging ...
Baqsimi
Baqsimi is used to treat very low blood sugar (severe hypoglycemia) in adults and children aged 1 ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Gvoke
Gvoke is used subcutaneously to treat very low blood sugar (severe hypoglycemia) in people with ...
Regadenoson
Regadenoson is used for diagnosis and investigation, radionuclide myocardial perfusion study
Gadobutrol
Gadobutrol is used for CNS Magnetic Resonance Imaging, diagnosis and investigation, vascular ...
Arginine
Arginine is used for diagnosis and investigation, dietary supplementation
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.